APA

Gion M., Mione R., Barioli P., Barichello M., Zattoni F., Prayer-Galetti T., Plebani M., Aimo G., Terrone C., Manferrari F., Madeddu G., Caberlotto L., Fandella A., Pianon C. & Vianello L. (19990105). Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. : Clinical chemistry.

Chicago

Gion M, Mione R, Barioli P, Barichello M, Zattoni F, Prayer-Galetti T, Plebani M, Aimo G, Terrone C, Manferrari F, Madeddu G, Caberlotto L, Fandella A, Pianon C and Vianello L. 19990105. Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. : Clinical chemistry.

Harvard

Gion M., Mione R., Barioli P., Barichello M., Zattoni F., Prayer-Galetti T., Plebani M., Aimo G., Terrone C., Manferrari F., Madeddu G., Caberlotto L., Fandella A., Pianon C. and Vianello L. (19990105). Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. : Clinical chemistry.

MLA

Gion M, Mione R, Barioli P, Barichello M, Zattoni F, Prayer-Galetti T, Plebani M, Aimo G, Terrone C, Manferrari F, Madeddu G, Caberlotto L, Fandella A, Pianon C and Vianello L. Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. : Clinical chemistry. 19990105.